The Board of Management of Deutsche Telekom AG plans to propose to the annual shareholder meeting to increase the dividend for the 2024 financial year to 0.90 euros per dividend-bearing share, up from ...

Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa ...

As part of this transaction, ElringKlinger AG will recognize non-cash impairment losses in the mid to high double-digit million euro range as of the end of the third quarter of 2024. These relate ...

30.09.24 VW Vz.: Gehebelte Renditechancen mit (Turbo)-Calls bei Kurserholung - Optionsscheineanalyse (4105 Klicks) 01.10.24 Siemens-(Turbo)-Calls mit hohen Chancen bei Erreichen des Jahreshochs ...

Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria ...

27.09 Meyer Burger gibt vorläufige. 27.09 Meyer Burger announces pre. 27.09 Arbonia ernennt Uwe Schille. 27.09 Arbonia appoints Uwe Schill. 27.09 EQS-Adhoc: AOC I DIE ST. 27.09 EQS-Adhoc: ZF ...

27.09 Meyer Burger gibt vorläufige. 27.09 Meyer Burger announces pre. 27.09 Arbonia ernennt Uwe Schille. 27.09 Arbonia appoints Uwe Schill. 27.09 EQS-Adhoc: AOC I DIE ST. 27.09 EQS-Adhoc: ZF ...

Change in Forecast/Development of Sales Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025 30-Sep-2024 / 16:21 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the ...

30.09 Xlife Sciences AG ermöglich. 30.09 EQS-Adhoc: flatexDEGIRO s. 30.09 EQS-Adhoc: flatexDEGIRO l. 30.09 EQS-Adhoc: ARI Motors Ind. 30.09 EQS-Adhoc: aconnic AG ve. 30.09 EQS-Adhoc: aconnic AG pu.

Consequently, Francotyp-Postalia Holding AG has adjusted its forecast for 2024. Considering the business area as a discontinued business area, the contribution of freesort GmbH to Group revenue and ...

Ladenburg, Germany, 1 October 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announces that it has adjusted its ...